|
Nov 12
|
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
|
|
Oct 1
|
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
|
|
Sep 30
|
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
|
|
Jul 25
|
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
|
|
Jul 23
|
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jun 19
|
BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold
|
|
Jun 17
|
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
|
|
Jun 14
|
BrainsWay (BWAY) to Advance in DEEP TMS for MDD With New Trial
|
|
May 8
|
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
|
|
Mar 28
|
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
|
|
Mar 27
|
After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY)
|
|
Jan 10
|
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
|
|
Dec 22
|
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
|
|
Dec 19
|
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
|
|
Dec 8
|
BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS
|
|
Dec 7
|
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
|
|
Nov 29
|
Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Nov 28
|
Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going
|
|
Sep 27
|
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
|
|
Aug 23
|
BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region
|